May 2019 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2019. This roundup includes the latest...
Guidelines Issued for Addressing Heart Disease Risk in HIV
Individuals with HIV have significantly higher rates of CVD, may have underuse of statins, antithrombotics
FDA Takes Hard Look at CBD
CBD products have swamped the market due to change in federal law, not because of new medical evidence
ACP Issues Position on Response to Physician Impairment
Rehabilitated doctors should be reintegrated into practice as long as patient safety not compromised
Higher LDL-C Levels Linked to Early-Onset Alzheimer Disease
Cases with EOAD have higher levels of LDL-C, greater frequency of rare genetic coding variants of APOB
Lupus Manifestations Appear to Differ by Race, Ethnicity
Increased risk for severe manifestations seen among blacks, Hispanics, and Asians/Pacific Islanders
Recommendations Developed for Pediatric Multiple Sclerosis Trials
Biological rationale exists for using treatments proven efficacious in adults with MS for pediatric MS
High Costs Associated With Physician Burnout in U.S.
Nationally, about $4.6 billion in costs are related to physician turnover, reduced clinical hours
Ultra-Processed Food Intake Linked to Increased CVD Risk
Second study shows consumption associated with all-cause mortality with significant dose-response link
Pediatric Nurse Practitioner Shortage Looming
White paper calls for research on practice and policy to support maximizing contributions of PNPs
